AR244551A1 - Procedimiento para la obtencion de una composicion que contiene alfa-interferon. - Google Patents

Procedimiento para la obtencion de una composicion que contiene alfa-interferon.

Info

Publication number
AR244551A1
AR244551A1 AR90317958A AR31795890A AR244551A1 AR 244551 A1 AR244551 A1 AR 244551A1 AR 90317958 A AR90317958 A AR 90317958A AR 31795890 A AR31795890 A AR 31795890A AR 244551 A1 AR244551 A1 AR 244551A1
Authority
AR
Argentina
Prior art keywords
leucocyte
interferon
stabilized
stabilized leucocyte
Prior art date
Application number
AR90317958A
Other languages
English (en)
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of AR244551A1 publication Critical patent/AR244551A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/28Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AR90317958A 1989-09-28 1990-09-26 Procedimiento para la obtencion de una composicion que contiene alfa-interferon. AR244551A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH351489 1989-09-28

Publications (1)

Publication Number Publication Date
AR244551A1 true AR244551A1 (es) 1993-11-30

Family

ID=4257630

Family Applications (1)

Application Number Title Priority Date Filing Date
AR90317958A AR244551A1 (es) 1989-09-28 1990-09-26 Procedimiento para la obtencion de una composicion que contiene alfa-interferon.

Country Status (26)

Country Link
EP (1) EP0420049B1 (es)
JP (1) JPH03130232A (es)
KR (1) KR910005886A (es)
CN (1) CN1050503A (es)
AR (1) AR244551A1 (es)
AT (1) ATE92334T1 (es)
AU (1) AU636653B2 (es)
CA (1) CA2024046A1 (es)
CZ (1) CZ277712B6 (es)
DD (1) DD298054A5 (es)
DE (1) DE59002183D1 (es)
FI (1) FI904756A0 (es)
HU (1) HU205555B (es)
IE (1) IE903479A1 (es)
IL (1) IL95769A0 (es)
IS (1) IS3631A7 (es)
MC (1) MC2149A1 (es)
MX (1) MX22522A (es)
MY (1) MY106615A (es)
NO (1) NO904218L (es)
NZ (1) NZ235153A (es)
PH (1) PH27531A (es)
PT (1) PT95454A (es)
RU (1) RU2008017C1 (es)
YU (1) YU184090A (es)
ZA (1) ZA907579B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU6794194A (en) * 1993-05-18 1994-12-20 Bukh Meditec A/S A method for the preparation of interferons
DE69715883T2 (de) * 1996-05-09 2003-07-31 Feronpatent Ltd., Gibraltar Stabilisierung von interferonen in wässriger lösung durch gummiarabikum
WO1998051328A1 (en) * 1997-05-09 1998-11-19 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
US6180096B1 (en) 1998-03-26 2001-01-30 Schering Corporation Formulations for protection of peg-interferon alpha conjugates
PT1066059E (pt) * 1998-03-26 2005-10-31 Schering Corp Formulacoes para proteccao de conjugados de peg-interferao alfa
CN1175901C (zh) * 1999-12-06 2004-11-17 天津华立达生物工程有限公司 一种稳定的干扰素水溶液
US7632491B2 (en) 2004-08-12 2009-12-15 Schering Corporation Stable pegylated interferon formulation
DE102004048379A1 (de) 2004-10-01 2006-04-13 "Stiftung Caesar" (Center Of Advanced European Studies And Research) Federelement aus gesputterter Formgedächtnis-Legierung
CU23432B6 (es) * 2005-11-02 2009-10-16 Ct Ingenieria Genetica Biotech Formulaciones estabilizadas que contienen a los interferones gamma y alfa en proporciones potenciadoras

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5821691A (ja) * 1981-07-29 1983-02-08 Mochida Pharmaceut Co Ltd α−及びβ−インタ−フェロンの精製方法
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
EP0124018B1 (en) * 1983-04-28 1987-11-25 Armour Pharmaceutical Company Pharmaceutical preparation containing purified fibronectin
EP0133767B1 (en) * 1983-08-04 1991-04-03 The Green Cross Corporation Gamma interferon composition
IL78231A (en) * 1985-03-25 1990-07-26 Schering Corp Stable gamma-interferon formulation
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones

Also Published As

Publication number Publication date
EP0420049B1 (de) 1993-08-04
HU906021D0 (en) 1991-03-28
AU636653B2 (en) 1993-05-06
MY106615A (en) 1995-06-30
AU6309890A (en) 1991-04-11
DD298054A5 (de) 1992-02-06
MC2149A1 (fr) 1992-03-10
PT95454A (pt) 1991-05-22
NZ235153A (en) 1993-03-26
CZ277712B6 (en) 1993-03-17
CA2024046A1 (en) 1991-03-29
YU184090A (sh) 1992-09-07
HU205555B (en) 1992-05-28
IE903479A1 (en) 1991-04-10
IL95769A0 (en) 1991-06-30
MX22522A (es) 1993-10-01
ATE92334T1 (de) 1993-08-15
KR910005886A (ko) 1991-04-27
FI904756A0 (fi) 1990-09-27
CS432890A3 (en) 1992-12-16
ZA907579B (en) 1991-06-26
PH27531A (en) 1993-08-18
HUT56284A (en) 1991-08-28
IS3631A7 (is) 1991-03-29
DE59002183D1 (de) 1993-09-09
NO904218D0 (no) 1990-09-27
CN1050503A (zh) 1991-04-10
NO904218L (no) 1991-04-02
EP0420049A1 (de) 1991-04-03
RU2008017C1 (ru) 1994-02-28
JPH03130232A (ja) 1991-06-04

Similar Documents

Publication Publication Date Title
DE4090310D2 (en) Teleskopkrone
DE68927004D1 (en) Multiplex-synchron/asynchron-datenbus
AU108277S (en) Hedge-shears
DE3991623D2 (en) Frequenzueberwachungsanordnung
CS9005442A2 (en) Symmetrizer
CS490790A3 (en) Chaff-cutter
AR244551A1 (es) Procedimiento para la obtencion de una composicion que contiene alfa-interferon.
DE4091364D2 (en) Thermosaeulen-strahlungsdetektor
DE4090110D2 (en) Rotationskolbenverbrennungskraftmaschine
DE4091275D2 (en) Steppdecke
BG49771A1 (en) Electric- bow evaparator
DE69027068D1 (en) Spiropyranverbindungen
DE4090763D2 (en) Abfallsammler
DE69030237D1 (en) Kalispenderzubereitung
DE3991686D2 (de) Schmuckblende
DE4091102D2 (de) Spundlochverschluss
DE3991687D2 (de) Dufttresor
DE4090235D2 (de) Hauptabsperrventil
EP0413662A3 (en) Polyaryleneethers
YU26690A (en) Izomeric didezoxynucleozides
EP0419411A3 (en) Additional alkanophenones
CA64817S (en) Liminaire
DE69024223D1 (en) Fluidmaschine
DE3991146D2 (en) Schraubverschluss
CA64838S (en) Automibile